These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 23835309)
41. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221 [TBL] [Abstract][Full Text] [Related]
42. [Prognostic significance of sex steroid and hypophyseal hormones in head and neck squamous cell carcinoma]. Remenár E; Számel I; Budai B; Orosz Z; Gaudi I; Kásler M; Gundy S Magy Onkol; 2003; 47(2):155-9. PubMed ID: 12975662 [TBL] [Abstract][Full Text] [Related]
43. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Sato F; Shimada Y; Li Z; Watanabe G; Maeda M; Imamura M Br J Surg; 2001 Mar; 88(3):426-32. PubMed ID: 11260111 [TBL] [Abstract][Full Text] [Related]
44. Micrometastatic tumor detection in patients with head and neck cancer: a preliminary report. Wirtschafter A; Benninger MS; Moss TJ; Umiel T; Blazoff K; Worsham MJ Arch Otolaryngol Head Neck Surg; 2002 Jan; 128(1):40-3. PubMed ID: 11784252 [TBL] [Abstract][Full Text] [Related]
45. Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results. Jatana KR; Balasubramanian P; Lang JC; Yang L; Jatana CA; White E; Agrawal A; Ozer E; Schuller DE; Teknos TN; Chalmers JJ Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1274-9. PubMed ID: 21173379 [TBL] [Abstract][Full Text] [Related]
46. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis. Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076 [TBL] [Abstract][Full Text] [Related]
47. Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer. Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Aikou T Br J Surg; 2007 Aug; 94(8):984-91. PubMed ID: 17410638 [TBL] [Abstract][Full Text] [Related]
48. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523 [TBL] [Abstract][Full Text] [Related]
49. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy. Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646 [TBL] [Abstract][Full Text] [Related]
50. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Eibling DE; Johnson JT; Wagner RL; Su S Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421 [TBL] [Abstract][Full Text] [Related]
51. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas. Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286 [TBL] [Abstract][Full Text] [Related]
52. Commentary re: Q-T Le et al, identification of osteopontin as a prognostic marker for head and neck squamous cell carcinomas. clin cancer res, 9: 31-32, 2003. Denhardt DT Clin Cancer Res; 2003 Jan; 9(1):31-2. PubMed ID: 12538448 [No Abstract] [Full Text] [Related]
53. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845 [TBL] [Abstract][Full Text] [Related]
54. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers. Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363 [TBL] [Abstract][Full Text] [Related]
55. Combined therapy in advanced squamous cell carcinoma of the head and neck. LoVerme PJ; Rush BF; Legaspi A; Raina S; Swaminathan AP; Ohanian M Am Surg; 1982 May; 48(5):197-201. PubMed ID: 7081831 [TBL] [Abstract][Full Text] [Related]
56. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505 [TBL] [Abstract][Full Text] [Related]
57. The development of a liquid biopsy for head and neck cancers. Schmidt H; Kulasinghe A; Kenny L; Punyadeera C Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098 [TBL] [Abstract][Full Text] [Related]
58. Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method. Hofman V; Long E; Ilie M; Bonnetaud C; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Mourad N; Butori C; Selva E; Marquette CH; Poudenx M; Sibon S; Kelhef S; Vénissac N; Jais JP; Mouroux J; Molina TJ; Vielh P; Hofman P Cytopathology; 2012 Feb; 23(1):30-8. PubMed ID: 21210876 [TBL] [Abstract][Full Text] [Related]
59. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593 [TBL] [Abstract][Full Text] [Related]
60. Detection of circulating cancer cells in human oral squamous cell carcinoma. Zen H; Nakashiro K; Shintani S; Sumida T; Aramoto T; Hamakawa H Int J Oncol; 2003 Sep; 23(3):605-10. PubMed ID: 12888894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]